Stanley van Herk

Stanley van Herk is a researcher in the Department of Hematology at Erasmus Medical Center, specializing in molecular mechanisms of leukemia with a focus on myeloid disorders and epigenetic regulation. His work bridges basic science and clinical applications in hematological malignancies.

His primary research interests include:

• Myeloid leukemia pathogenesis
• Epigenetic regulation in hematopoiesis
• Chromatin architecture and gene expression
• Molecular classification of acute leukemias
• Transcriptional profiling approaches

Dr. van Herk's recent publications demonstrate significant contributions to understanding the molecular basis of acute leukemias, particularly through investigations of STAG2 mutations, epigenetic alterations in mixed lineage leukemias, and transcriptional profiling for leukemia classification. His research spans both myeloid and lymphoid malignancies with implications for improved diagnostic approaches.

He maintains active collaborations with leading researchers including R. M. Hoogenboezem, F. G. Kavelaars, and P. J. M. Valk, with his work receiving citations and attention across the hematology research community.